genomics

Genomics alone, therefore, cannot answer everything drug companies need to know.

But there are many other ways to play the genomics card.

The genomics companies are where the greatest potential return is.

This field of public health genomics is less than a decade old.

The idea of interdisciplinary work for genomics is not new.

Q. What impact will genomics really have on drug development?

The genomics field is not more than five years old."

But genomics has taken longer than expected to yield drugs.

Q. What progress has been made in genomics over the last year or two?

And genomics companies might want to do thousands of such searches a day.

"All you have to do is look at the aging population and genomics," she says.

Q. You think that genomics is the wave of the future.

For science and the genomics business, the papers are landmarks.

First, Wade says, genomics may point the way to ending disease.

The comparative information today is huge when compared to the early days of genomics.

The field of genomics is caught in a data deluge.

Novartis officials say they are moving the science of genomics ahead.

Many other companies that provide genomics information or technology for genetic analysis are making similar moves.

The final genomics breakthrough is a repeat from last year's list.

He is a leader in the field of genomics.

In the past decade, significantly more attention has been given to imaging genomics.

This area of genomics still remains a challenge and researchers are looking into how to address these questions.

The two agreements are another sign of how genomics is transforming drug development.

The increasing understanding and use of genomics may also undermine the insurance system.

The two organizations, in their different styles, have both helped put genomics on the map.